Cancer Clinical Trials & Investigational Medicine Units
Advance collaborative cancer research through a streamlined clinical trial start-up framework and facilitate multi-site studies via a national KOL network spanning Singapore’s three healthcare clusters
The Cancer Clinical Trials and Investigational Medicine Units (IMUs) platform aims to drive impactful and innovative clinical research, strengthening Singapore’s position as a leading destination for cancer clinical trials, oncology research, and investigational medicine. Our platform collaborates closely with research institutions, pharmaceutical companies, and biotechnology organizations across the public sector and industry, with a shared goal to expand patient access to innovative cancer treatments and advance the development of new therapies.
By bringing together the expertise, capabilities, and resources of Singapore’s three public healthcare clusters, our platform provides integrated solutions that streamline clinical trial conduct and accelerate the translation of research discoveries into improved patient outcomes.
How STCC Supports Cancer Clinical Trials
Multi-Centre Collaborative Framework
An established framework for collaborative multi-centre cancer research with streamlined contracting and centralised workflows to facilitate multi-centre studies.
Translational Cancer Research Collaborations
Active coordination and promotion of translational cancer research collaborations across and amongst the various Large Collaborative Grant (LCG) programmes and cancer groups.
National KOL Tumour Groups
A national Key Opinion Leader (KOL) network - the STCC Tumour Groups - comprising multidisciplinary experts from all three healthcare clusters in Singapore. The network works to develop strategic cancer research agenda aligned with national needs, shape Singapore's cancer research ecosystem through high-priority trials with strong translational value, and drive regional clinical trial networks for the conduct of cross-border studies.
KOL NETWORK
STCC Tumour Groups
Groups have been established in the following areas of cancer research:
Solid Tumours
Breast Cancers
Thoracic, Head and Neck Cancers
Gastrointestinal (GI) Cancers
Genito-urinary (GU) Cancers
Sarcoma and Rare Malignancies (including central nervous system cancers)
Haematologic Malignancies
Lymphoma
Leukaemia
Early Phase and Clinical Pharmacology
Phase 1 and Clinical Pharmacology
Nucleic Acid Therapeutics and Cancer Vaccines
Ready to collaborate or conduct a trial in Singapore?
From feasibility assessments to trial execution, reach out to discuss how we can support your study.
Explore cancer clinical trials
Discover currently recruiting cancer clinical trials through Singapore’s National Clinical Trials Portal (CTSG). Filter by selecting “Cancer” under the Therapeutic Area to find relevant studies.